SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017009
Filing Date
2022-11-09
Accepted
2022-11-09 07:23:41
Documents
89
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aplt-20220930x10q.htm   iXBRL 10-Q 2298248
2 EX-31.1 aplt-20220930xex31d1.htm EX-31.1 9717
3 EX-31.2 aplt-20220930xex31d2.htm EX-31.2 9715
4 EX-32.1 aplt-20220930xex32d1.htm EX-32.1 6240
5 EX-32.2 aplt-20220930xex32d2.htm EX-32.2 6394
  Complete submission text file 0001558370-22-017009.txt   9090594

Data Files

Seq Description Document Type Size
6 EX-101.SCH aplt-20220930.xsd EX-101.SCH 71181
7 EX-101.CAL aplt-20220930_cal.xml EX-101.CAL 57780
8 EX-101.DEF aplt-20220930_def.xml EX-101.DEF 270570
9 EX-101.LAB aplt-20220930_lab.xml EX-101.LAB 550837
10 EX-101.PRE aplt-20220930_pre.xml EX-101.PRE 473079
83 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20220930x10q_htm.xml XML 1546537
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38898 | Film No.: 221370652
SIC: 2834 Pharmaceutical Preparations